Abstract:Inflammation is associated with a variety of diseases. The hallmark of inflammation is leukocyte infiltration at disease sites in response to pathogen- or damage-associated chemotactic molecular patterns (PAMPs and MAMPs), which are recognized by a superfamily of seven transmembrane, Gi-protein-coupled receptors (GPCRs) on cell surface. Chemotactic GPCRs are composed of two major subfamilies: the classical GPCRs and chemokine GPCRs. Formyl-peptide receptors (FPRs) belong to the classical chemotactic GPCR subfamily with unique properties that are increasingly appreciated for their expression on diverse host cell types and the capacity to interact with a plethora of chemotactic PAMPs and MAMPs. Three FPRs have been identified in human: FPR1-FPR3, with putative corresponding mouse counterparts. FPR expression was initially described in myeloid cells but subsequently in many non-hematopoietic cells including cancer cells. Accumulating evidence demonstrates that FPRs possess multiple functions in addition to controlling inflammation, and participate in the processes of many pathophysiologic conditions. They are not only critical mediators of myeloid cell trafficking, but are also implicated in tissue repair, angiogenesis and protection against inflammation-associated tumorigenesis. A series recent discoveries have greatly expanded the scope of FPRs in host defense which uncovered the essential participation of FPRs in step-wise trafficking of myeloid cells including neutrophils and dendritic cells (DCs) in host responses to bacterial infection, tissue injury and wound healing. Also of great interest is the FPRs are exploited by malignant cancer cells for their growth, invasion and metastasis. In this article, we review the current understanding of FPRs concerning their expression in a vast array of cell types, their involvement in guiding leukocyte trafficking in pathophysiological conditions, and their capacity to promote the differentiation of immune cells, their participation in tumor-associated inflammation and cancer progression. The close association of FPRs with human diseases and cancer indicates their potential as targets for the development of therapeutics.

Identification of Fam3d As A New Endogenous Chemotaxis Agonist for the Formyl Peptide Receptors

Identification of FAM 3 D as a novel endogenous chemotaxis agonist for the FPRs ( formyl peptide receptors )

Chemogenetic analysis of how receptors for short chain fatty acids regulate the gut-brain axis

FAM19A4 is a Novel Cytokine Ligand of Formyl Peptide Receptor 1 (FPR1) and is Able to Promote the Migration and Phagocytosis of Macrophages.

Deficiency of FAM3D (family with Sequence Similarity 3, Member D), A Novel Chemokine, Attenuates Neutrophil Recruitment and Ameliorates Abdominal Aortic Aneurysm Development

Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor

Receptors for chemotactic formyl peptides as pharmacological targets

FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis

The Homeostatic Protein Fam3D Orchestrates Colon Mucosal Protection Against Infection, Inflammation, and Carcinogenesis

Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2

The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer

Regulation of inflammation by members of the formyl-peptide receptor family

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils

The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor

FAM3D regulation of head and neck squamous cell carcinoma behaviour through the EMT pathway

Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patterns

FAM53B Promotes Pancreatic Ductal Adenocarcinoma Metastasis by Regulating Macrophage M2 Polarization

Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse

Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria